CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 93 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $156,331 | +40.8% | 26,769 | +20.4% | 0.00% | – |
| Q1 2021 | $111,000 | -87.5% | 22,225 | -68.3% | 0.00% | -100.0% |
| Q4 2020 | $885,000 | +25.0% | 70,014 | -2.9% | 0.00% | +33.3% |
| Q3 2020 | $708,000 | -2.3% | 72,114 | -1.1% | 0.00% | -25.0% |
| Q2 2020 | $725,000 | -2.9% | 72,914 | -13.7% | 0.00% | -20.0% |
| Q1 2020 | $747,000 | -7.5% | 84,501 | -3.6% | 0.01% | +66.7% |
| Q4 2019 | $808,000 | +56.0% | 87,614 | -0.6% | 0.00% | +50.0% |
| Q3 2019 | $518,000 | -73.2% | 88,114 | -45.3% | 0.00% | -71.4% |
| Q2 2019 | $1,934,000 | -2.8% | 161,134 | -2.2% | 0.01% | -12.5% |
| Q1 2019 | $1,990,000 | -4.8% | 164,834 | -1.0% | 0.01% | -11.1% |
| Q4 2018 | $2,090,000 | -53.8% | 166,525 | -45.4% | 0.01% | -47.1% |
| Q3 2018 | $4,523,000 | -17.7% | 304,755 | -6.7% | 0.02% | -26.1% |
| Q2 2018 | $5,496,000 | -30.6% | 326,555 | -5.5% | 0.02% | -36.1% |
| Q1 2018 | $7,915,000 | – | 345,625 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |